中国老年人群疫苗接种意愿以及影响因素
Vaccination Willingness and Its Influencing Factors among the Elderly Population in China
DOI: 10.12677/ns.2025.1411264, PDF,   
作者: 伍宇婷*, 张 瑾, 靳雅鑫, 谭 瑶:湖北中医药大学护理学院,湖北 武汉;汪晓攀#:湖北省中西医结合医院护理部,湖北 武汉
关键词: 老年人流感疫苗肺炎链球菌疫苗带状疱疹疫苗Elderly Population Influenza Vaccines Pneumococcal Vaccines Herpes Zoster Vaccine
摘要: 老年人群是疫苗接种的重点关注人群,合理的疫苗接种可以有效降低疾病发生率。但我国老年人群流感、肺炎链球菌和带状疱疹疫苗接种意愿以及接种率偏低,低于高覆盖率国家以及发达国家,并且存在省际差异、城乡差异等问题。分析影响老年人群疫苗接种意愿的因素,可为后续采取针对性措施提供参考依据。
Abstract: The elderly population is a key target group for vaccination. Appropriate immunization can effectively reduce the incidence of vaccine-preventable diseases. However, in China, willingness and uptake rates for influenza, pneumococcal, and herpes zoster vaccines among older adults remain low. These rates are notably lower than those in high-coverage and developed countries, and significant disparities exist across different provinces and between urban and rural areas. Analyzing the factors that influence vaccination willingness in this demographic is crucial for informing subsequent targeted interventions.
文章引用:伍宇婷, 汪晓攀, 张瑾, 靳雅鑫, 谭瑶. 中国老年人群疫苗接种意愿以及影响因素[J]. 护理学, 2025, 14(11): 1972-1977. https://doi.org/10.12677/ns.2025.1411264

参考文献

[1] 王维国, 张逸君, 邱德馨. 人口老龄化、财政支出效率与产业结构升级[J]. 统计研究, 2024, 41(7): 134-147.
[2] 关于印发“十四五”健康老龄化规划的通知[J]. 中华人民共和国国家卫生健康委员会公报, 2022(2): 16-25.
[3] 周志军. 老年人患病特点[J]. 开卷有益-求医问药, 2023(6): 29.
[4] Weinberger, B. (2018) Vaccines for the Elderly: Current Use and Future Challenges. Immunity & Ageing, 15, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
[5] 我国老年人健康防护倡议专家组. 我国老年人健康防护倡议[J] . 中华医学杂志, 2022, 102(12) : 838-839.
[6] 中国流感疫苗预防接种技术指南(2023-2024) [J]. 中国病毒病杂志, 2024, 14(1): 1-19.
[7] 赵宏婷. 2010-2015年中国流感相关呼吸系统疾病超额死亡: 一项基于人群的研究[J]. 中华预防医学杂志, 2019, 53(10): 992-992.
[8] Maertzdorf, K.M., Rietman, M.L., Lambooij, M.S., Verschuren, W.M.M. and Picavet, H.S.J. (2023) Willingness to Get Vaccinated against Influenza, Pneumococcal Disease, Pertussis, and Herpes Zoster—A Pre-COVID-19 Exploration among the Older Adult Population. Vaccine, 41, 1254-1264. [Google Scholar] [CrossRef] [PubMed]
[9] Prada-García, C., Fernández-Espinilla, V., Hernán-García, C., Sanz-Muñoz, I., Martínez-Olmos, J., Eiros, J.M., et al. (2022) Attitudes, Perceptions and Practices of Influenza Vaccination in the Adult Population: Results of a Cross-Sectional Survey in Spain. International Journal of Environmental Research and Public Health, 19, Article 11139. [Google Scholar] [CrossRef] [PubMed]
[10] Pereira, J.A., Gilca, V., Waite, N. and Andrew, M.K. (2019) Canadian Older Adults’ Perceptions of Effectiveness and Value of Regular and High-Dose Influenza Vaccines. Human Vaccines & Immunotherapeutics, 15, 487-495. [Google Scholar] [CrossRef] [PubMed]
[11] Katsiroumpa, A., Sourtzi, P., Kaitelidou, D., Siskou, O., Konstantakopoulou, O. and Galanis, P. (2023) Predictors of Seasonal Influenza Vaccination Willingness among High-Risk Populations Three Years after the Onset of the COVID-19 Pandemic. Vaccines, 11, Article 331. [Google Scholar] [CrossRef] [PubMed]
[12] Worasathit, R., Wattana, W., Okanurak, K., Songthap, A., Dhitavat, J. and Pitisuttithum, P. (2015) Health Education and Factors Influencing Acceptance of and Willingness to Pay for Influenza Vaccination among Older Adults. BMC Geriatrics, 15, Article No. 136. [Google Scholar] [CrossRef] [PubMed]
[13] 湖南省预防医学会. 流感疫苗公费接种项目方案专家共识[J]. 中华预防医学杂志, 2020, 54(12): 1364-1377.
[14] Lu, P., Hung, M., Srivastav, A., Grohskopf, L.A., Kobayashi, M., Harris, A.M., et al. (2021) Surveillance of Vaccination Coverage among Adult Populations—United States, 2018. MMWR. Surveillance Summaries, 70, 1-26. [Google Scholar] [CrossRef] [PubMed]
[15] The United Kingdom Government (2022) Seasonal Vaccine Uptake in GP Patients : Monthly Data, 2021to2022.
https://www.gov.uk/government/statistics/seasonal-flu-vaccine-uptake-in-gp-patients-monthly-data-2021-to-2022
[16] 孟庆红, 姚开虎. 肺炎链球菌临床感染疾病谱[J]. 中华全科医学, 2018, 16(9): 1535-1539+1544.
[17] 刘聚源, 纪文艳, 吴疆. 北京市老年人肺炎多糖疫苗接种成本效益分析[J]. 中国公共卫生, 20, 27(2): 191-193.
[18] 李春颖, 李泽庚, 王胜, 等. 老年肺炎现代研究近况[J]. 辽宁中医药大学学报, 2016, 18(7): 221-224.
[19] 中华预防医学会, 中华预防医学会疫苗与免疫分会. 肺炎球菌性疾病免疫预防专家共识(2017版) [J]. 中华流行病学杂志, 2018, 39(2): 111-138.
[20] U. S. Department of Health and Human Services (2012) Healthy People 2010 Final Review.
[21] Baig, S.A., Hassan, M., Ahmed, S.M., Moazzam, W. and Inayat, A. (2014) A Cross-Sectional Study to Investigate Pneumococcal Vaccination in the Elderly in a Low Income County: Patient Knowledge, Awareness, and Attitudes of Vaccination and Prevalence Rates by Socioeconomic Status. Human Vaccines & Immunotherapeutics, 10, 1024-1027. [Google Scholar] [CrossRef] [PubMed]
[22] Liu, S., Xu, E., Liu, Y., Xu, Y., Wang, J., Du, J., et al. (2014) Factors Associated with Pneumococcal Vaccination among an Urban Elderly Population in China. Human Vaccines & Immunotherapeutics, 10, 2994-2999. [Google Scholar] [CrossRef] [PubMed]
[23] Di Giuseppe, G., Pelullo, C.P., Napoli, A. and Napolitano, F. (2023) Willingness to Receive Herpes Zoster Vaccination among Adults and Older People: A Cross Sectional Study in Italy. Vaccine, 41, 7244-7249. [Google Scholar] [CrossRef] [PubMed]
[24] 黄淑雅, 宋静卉, 邢丽媛. 郑州地区≥ 50岁居民带状疱疹疫苗接种意愿及影响因素调查[J]. 华南预防医学, 2022, 48(6): 752-755.
[25] 仇静, 孙晓冬, 胡家瑜, 等. 2020年5-6月上海市≥ 50岁成人带状疱疹疫苗接种意愿调查[J]. 中国疫苗和免疫, 2021, 27(3): 307-310+327.
[26] Kennedy, P.G.E. (2002) Varicella-Zoster Virus Latency in Human Ganglia. Reviews in Medical Virology, 12, 327-334. [Google Scholar] [CrossRef] [PubMed]
[27] Gilden, D., Cohrs, R.J., Mahalingam, R. and Nagel, M.A. (2009) Varicella Zoster Virus Vasculopathies: Diverse Clinical Manifestations, Laboratory Features, Pathogenesis, and Treatment. The Lancet Neurology, 8, 731-740. [Google Scholar] [CrossRef] [PubMed]
[28] Gershon, A.A., Breuer, J., Cohen, J.I., Cohrs, R.J., Gershon, M.D., Gilden, D., et al. (2015) Varicella Zoster Virus Infection. Nature Reviews Disease Primers, 1, Article No. 15016. [Google Scholar] [CrossRef] [PubMed]
[29] The United Kingdom Government (2023) Shingles Vaccine Coverage (England): Report for Quarter 2 of the Financial Year 2022 to 2023.
https://www.gov.uk/government/publications/herpes-zoster-shingles-immunisation-programme-2022-to-2023-evaluation-reports
[30] Lu, X., Lu, J., Zhang, F., Wagner, A.L., Zhang, L., Mei, K., et al. (2021) Low Willingness to Vaccinate against Herpes Zoster in a Chinese Metropolis. Human Vaccines & Immunotherapeutics, 17, 4163-4170. [Google Scholar] [CrossRef] [PubMed]
[31] Di Valerio, Z., La Fauci, G., Scognamiglio, F., Salussolia, A., Montalti, M., Capodici, A., et al. (2024) Pneumococcal Vaccine Uptake among High-Risk Adults and Children in Italy: Results from the OBVIOUS Project Survey. BMC Public Health, 24, Article No. 736. [Google Scholar] [CrossRef] [PubMed]
[32] 中华医学会全科医学分会, 中华医学会杂志社, 中华医学会《中华全科医师杂志》编辑委员会, 等. 社区老年人常见感染性疾病疫苗应用专家共识[J]. 中华全科医师杂志, 2022, 21(1): 6-23.
[33] 方任飞, 马彦, 吴疆, 等. 北京市老年人免费流感疫苗接种率及认知影响因素调查分析[J]. 中国全科医学, 2014, 17(12): 1403-1406.
[34] 程立雪, 李力, 曹雷, 等. 2019-2023年全国≥ 60岁人群3种非免疫规划疫苗接种情况分析[J]. 中国预防医学杂志, 2024, 25(5): 592-597.
[35] 王迪, 孙昊, 陈娅妮, 等. 2023年北京市东城区≥ 50岁居民流感疫苗、23价肺炎球菌多糖疫苗和带状疱疹疫苗接种意愿调查[J]. 中国疫苗和免疫, 2024, 30(2): 141-148.
[36] 沈瑜, 孟晓军, 王成春, 等. 2023年无锡市60岁及以上老年人流感样症状发生情况及流感疫苗接种意愿调查[J]. 预防医学情报杂志, 2025, 41(4): 536-44, 56.
[37] 王文畅, 王华庆. 中国非免疫规划疫苗接种现状和影响因素浅析[J]. 中国疫苗和免疫, 2020, 26(1): 93-97.
[38] 王小龙, 张恩铭, 戴正悦, 等. 上海市老年人带状疱疹疫苗犹豫现状及影响因素[J]. 中国预防医学杂志, 2024, 25(2): 222-227.